| Dec'17 | Dec'16 | Dec'15 | ||||
|---|---|---|---|---|---|---|
Continuing operations | ||||||
General and administrative expenses | ||||||
8,541 | 4,912 | 3,577 | ||||
Research and development expenses | ||||||
29,475 | 34,794 | 4,680 | ||||
Gains on settlement of contract disputes | ||||||
- | 83 | 5 | ||||
Operating loss | ||||||
-38,016 | -39,623 | -8,253 | ||||
Interest income | ||||||
133 | 69 | 15 | ||||
Interest expense | ||||||
275 | 383 | 268 | ||||
Net foreign exchange losses | ||||||
238 | 250 | 9 | ||||
Loss from revaluation of derivative liabilities | ||||||
6,391 | 135 | - | ||||
Loss before income taxes | ||||||
-44,788 | -40,324 | -8,515 | ||||
Income tax expense | ||||||
22 | 0 | 0 | ||||
Net loss for the year | ||||||
-44,810 | -40,324 | -8,516 | ||||
Total comprehensive loss for the year | ||||||
-44,810 | -40,324 | -8,516 | ||||
Net loss per share | ||||||
Basic and diluted per share | ||||||
-0.19 | -0.35 | -0.14 | ||||
Weighted average number of ordinary shares, basic and diluted | ||||||
231,530 | 116,558 | 61,225 | ||||